These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2845554

  • 1. [Pathogenesis and treatment of multiple sclerosis. Review and personal results].
    Gérard JM, Hildebrand J, Mavroudakis N, Monseu G, Przedborski S, Seeldrayers P, Wautier J, Zegers de Beyl D.
    Rev Med Brux; 1988 Sep; 9(6):334-9. PubMed ID: 2845554
    [No Abstract] [Full Text] [Related]

  • 2. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
    Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL.
    N Engl J Med; 1983 Jan 27; 308(4):173-80. PubMed ID: 6294517
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC.
    NITA; 1985 Jan 27; 8(6):503-5. PubMed ID: 2999647
    [No Abstract] [Full Text] [Related]

  • 4. Immunosuppressive treatment of multiple sclerosis.
    Schweitzer SF.
    J Neurosurg Nurs; 1985 Aug 27; 17(4):256-9. PubMed ID: 2993548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide in chronic progressive multiple sclerosis.
    Wenala M.
    NITA; 1987 Aug 27; 10(3):219-23. PubMed ID: 3037447
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression].
    Wender M, Tokarz-Kupczyk E, Mularek O.
    Neurol Neurochir Pol; 1989 Aug 27; 23(3):188-92. PubMed ID: 2561379
    [Abstract] [Full Text] [Related]

  • 9. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
    Gladstone DE, Zamkoff KW, Krupp L, Peyster R, Sibony P, Christodoulou C, Locher E, Coyle PK.
    Arch Neurol; 2006 Oct 27; 63(10):1388-93. PubMed ID: 16908728
    [Abstract] [Full Text] [Related]

  • 10. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U, Majeron M, Mascetti A.
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb 29; 96(1):163-84. PubMed ID: 4337775
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of multiple sclerosis.
    McFarlin DE.
    N Engl J Med; 1983 Jan 27; 308(4):215-7. PubMed ID: 6294519
    [No Abstract] [Full Text] [Related]

  • 12. Home intravenous administration of adrenocorticotropic hormone in patients with multiple sclerosis.
    Molitor RE, Stewart J.
    J Intraven Nurs; 1988 Jan 27; 11(4):249-51. PubMed ID: 2843618
    [No Abstract] [Full Text] [Related]

  • 13. The treatment of multiple sclerosis with ACTH.
    Stetzler W.
    Minn Med; 1966 Feb 27; 49(2):323-9. PubMed ID: 4285449
    [No Abstract] [Full Text] [Related]

  • 14. [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies].
    Pette M, Hartung HP, Toyka KV.
    Nervenarzt; 1994 Apr 27; 65(4):271-4. PubMed ID: 8015636
    [No Abstract] [Full Text] [Related]

  • 15. Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
    Cendrowski W.
    Acta Neurol Belg; 1973 Apr 27; 73(4):209-19. PubMed ID: 4770124
    [No Abstract] [Full Text] [Related]

  • 16. [Pulse-dose cyclophosphamide therapy for chronic progressive multiple sclerosis].
    Watanabe T, Yamamoto T, Saito T, Sugano M, Tsukamoto T.
    Rinsho Shinkeigaku; 1993 Jan 27; 33(1):15-20. PubMed ID: 8334769
    [Abstract] [Full Text] [Related]

  • 17. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
    Blustein H, Wasserman RR, Halperin L, Garvin JS.
    Med Times; 1969 Dec 27; 97(12):137-41. PubMed ID: 4312534
    [No Abstract] [Full Text] [Related]

  • 18. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.
    Rose AS, Kuzma JW, Kurtzke JF, Sibley WA, Tourtellotte WW.
    Trans Am Neurol Assoc; 1969 Dec 27; 94():126-33. PubMed ID: 4313957
    [No Abstract] [Full Text] [Related]

  • 19. Cumulative experience with high-dose intravenous cyclophosphamide and ACTH therapy in chronic progressive multiple sclerosis.
    Carter JL, Dawson DM, Hafler DA, Fallis RJ, Stazzone L, Orav J, Weiner HL.
    Ann N Y Acad Sci; 1988 Dec 27; 540():535-6. PubMed ID: 2849902
    [No Abstract] [Full Text] [Related]

  • 20. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
    Cendrowski WS.
    Schweiz Arch Neurol Neurochir Psychiatr; 1969 Dec 27; 105(2):241-6. PubMed ID: 4314087
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.